Product Information
PHENTERMINE 30 MG CAPSULE is a generic product labeled by TAGI Pharma Inc., priced at $0.1114 per EA under NDC 51224020250. Its NADAC has been published 589 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224020250
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202248On Market Since
2/17/2012
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 30 MG CAPSULE has been published 589 times since Nov 28, 2013, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1114 per EA |
|---|---|
| All-time high | $0.2543 (Feb 12, 2014) |
| All-time low | $0.1044 (Jul 17, 2024) |
| Median price | $0.1626 |
| Average price | $0.1669 |
| Largest weekly change | +58.1% (Mar 20, 2024) |
| Weeks tracked | 589 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 30 MG CAPSULE, manufactured by TAGI Pharma Inc., is $0.1114 per EA (NDC 51224020250), effective Mar 5, 2025.
How has the price of PHENTERMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 30 MG CAPSULE has declined 49.1%. It has been tracked across 589 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PHENTERMINE 30 MG CAPSULE has ranged from a low of $0.1044 (Jul 17, 2024) to a high of $0.2543 (Feb 12, 2014), with a median of $0.1626 per EA.
Are there cheaper alternatives to PHENTERMINE 30 MG CAPSULE?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 30 MG CAPSULE, is $0.1044 per EA — about 6% below PHENTERMINE 30 MG CAPSULE.
Who manufactures PHENTERMINE 30 MG CAPSULE?
PHENTERMINE 30 MG CAPSULE (NDC 51224020250) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification